Frédéric Becq

Title: Frédéric Becq: Innovator in Cystic Fibrosis Treatment

Introduction

Frédéric Becq is a notable inventor based in Aix en Provence, France. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of cystic fibrosis. His innovative work has led to the development of compounds that can potentially improve the quality of life for those affected by this condition.

Latest Patents

Frédéric Becq holds 1 patent for his invention titled "CFTR channel activator compounds and pharmaceutical compositions containing same." This patent focuses on CFTR channel activator compounds from the benzo[c]quinolizinium family or related compounds. The patent also details pharmaceutical compositions that include these compounds and their uses, especially in treating cystic fibrosis.

Career Highlights

Becq is affiliated with the Centre National de la Recherche Scientifique, a prestigious research institution in France. His work there has allowed him to explore and develop innovative solutions in the pharmaceutical field. His research has been instrumental in advancing the understanding and treatment of cystic fibrosis.

Collaborations

Frédéric Becq has collaborated with notable colleagues such as Yvette Mettey and Jean-Michel Vierfond. These partnerships have contributed to the success of his research and the development of his patented compounds.

Conclusion

Frédéric Becq's contributions to the field of cystic fibrosis treatment through his innovative patents and collaborations highlight his importance as an inventor. His work continues to pave the way for advancements in pharmaceutical compositions aimed at improving patient outcomes.